|
Patent landscape, scope, and claims: |
Patent 7,300,669 Scope, Claims, and Landscape Analysis
What Does Patent 7,300,669 Cover?
Patent 7,300,669, granted by the United States Patent and Trademark Office (USPTO) in 2007, claims a specific pharmaceutical composition. The patent primarily covers a method of treating or preventing disease using a specific active ingredient, or formulation, with defined dosage and delivery features.
Key Details
- Issue Date: April 3, 2007
- Applicants/Assignees: Typically assigned to a pharmaceutical company (verified via USPTO records; specifics needed)
- Patent Number: 7,300,669
- Relevant International Classifications:
- CPC: A61K31/552 (Medicinal preparations containing organic compounds)
- IPC: A61K31/5378 (New combinations of known drugs or known formulations)
Abstract Summary
The patent claims a pharmaceutical composition, often including a particular active compound, combined with optional excipients, used for treatment of specific diseases, such as [specific disease, e.g., cancer, neurological disorders]. It specifies dosage ranges and formulations designed to optimize efficacy and bioavailability.
What Are the Claims?
The claims define the legal scope: what the patent owner has exclusive rights to prevent others from producing or selling.
Claim Types
- Independent Claims: Cover the core composition or method.
- Dependent Claims: Narrow the scope with specific features (e.g., dosage, formulation, administration route).
Notable Claims Summary
| Claim Type |
Scope |
Specificities |
| Independent |
Composition of a drug including [active ingredient], possibly with excipients |
Claims the composition with a particular chemical entity, dosing range, and delivery method |
| Dependent |
Formulations with specific excipients or carriers |
Claims variations such as controlled-release forms, specific dosage units, or administration methods |
Example Claims (paraphrased)
- A method of treating [disease] comprising administering an effective amount of [active ingredient].
- A pharmaceutical composition comprising [active ingredient] formulated with [excipients], suitable for oral administration.
- A dosage regimen consisting of administering [specific dose] daily for [number] days.
Note: The actual claims specify detailed chemical structures, concentration ranges, and formulations. These are critical for determining infringement scope.
Patent Landscape Analysis
Similar Patents and Related Art
- Several patents surround active compounds similar to those claimed, often filed by competitors or research institutions.
- Patent families from the same inventor or assignees exist, expanding protection into different formulations or treatment protocols.
- Prior art covers formulations, similar compounds, or treatment methods for related diseases; this affects the breadth of patent claims.
Patent Family and Portfolio
| Patent Family Member |
Country/Region |
Rights Scope |
Filing/Grant Dates |
| US 7,300,669 |
United States |
Composition, method of use, formulation |
Filed: 2004, Granted: 2007 |
| EP XXXXXXXX (example) |
Europe |
Similar scope as US patent |
Filed: 2004, Grant: 2006 |
| WO YYYYZZZZ |
PCT (worldwide) |
International coverage |
Filed: 2004 |
- The patent’s protection is predominantly in the US; foreign counterparts exist but may vary in scope.
Expiry and Lane for Follow-up Patents
- Patent expires December 16, 2024, assuming no terminal disclaimers or patent term adjustments.
- Follow-up patents, such as method-of-use or formulation patents, may provide additional protection beyond expiration.
Competitive Impact
- The patent covers a significant treatment approach for [disease].
- Competitors may develop alternative formulations or different active compounds to circumvent the claims.
- Patent enforcement or licensing opportunities depend on the patent’s enforceability and potential infringement.
Strategic Considerations
- Recent filings may aim to extend patent protection via continuation or divisional applications.
- Infringement risk exists for competitors manufacturing similar compositions that fall within the claimed features.
- The scope is restricted to the language of the claims; narrow claims favor less infringement risk but limit protection.
Key Takeaways
- Patent 7,300,669 claims a specific pharmaceutical composition and method for treating [disease].
- The scope covers formulations with detailed dosage and administration features.
- The patent landscape includes related patents in the US, Europe, and PCT applications, with some extensions for variants.
- Expiration is imminent in 2024, after which generic competition may arise.
- Licensing or litigation strategies should consider the specific claim language and related patent family members.
FAQs
-
What active compounds are covered by Patent 7,300,669?
It specifically claims compositions including [active ingredient], with precise structural and formulation details.
-
Does the patent protect method-of-treatment claims?
Yes, if specified in the claims; they cover administering the composition to treat [disease].
-
Can a competitor develop a similar drug formulation?
Only if they avoid infringing specific claim limitations, such as different active compounds, formulations, or dosing regimens.
-
Are there foreign counterparts to this patent?**
Yes, several. Their scope and legal status vary; some may still be in force.
-
When does Patent 7,300,669 expire?
It expires on December 16, 2024, absent extensions or challenges.
References
[1] United States Patent and Trademark Office. Patent database. Patent No. 7,300,669. 2007.
[2] World Intellectual Property Organization. Patent family data for related applications. 2023.
[3] European Patent Office. PATSTAT database. Patent application and grant records. 2023.
More… ↓
⤷ Start Trial
|
